Comparison of PRISM III, PIM2 and PELOD Scoring Systems

Comparison Of PRISM III, PIM2 And PELOD Scoring Systems In Predicting Mortality For Patients Undergoing Congenital Cardiac Surgery In Pediatric Intensive Care Unit

PRISMIII(Pediatric Risk of Mortality III), PIM2(Pediatric Index of Mortality 2) and PELOD(Pediatric Logistic Organ Dysfunction) are frequently used for predicting mortality and morbidity in general pediatric ICUs(Intensive Care Units). However, the effectiveness of these scoring sistems in a specific group patients undergoing congenital heart surgery(CHS) is unknown. In this study, the investigators aimed primarily to evaluate the success of these scoring systems in predicting mortality and morbiditiy in this specific group and to compare the scoring systems with eachother, and secondly to evaluate the relationship of these systems with the STAT(STS-EACTS CHS Mortality Score) category

Study Overview

• Status: Completed
• Conditions: Congenital Heart Disease

• Study Type: Observational
• Enrollment (Actual): 116

Contacts and Locations

Study Locations

• Turkey
  • Istanbul, Turkey
    • siyami ersek TRH

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 1 day to 18 years (Child, Adult)
• Accepts Healthy Volunteers: N/A
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

Patients younger than 18 years of age who had undergone congenital heart surgery

Description

Inclusion Criteria:

• Patients younger than 18 years of age who had undergone congenital heart surgery

Exclusion Criteria:

• emergency operations Patients staying in intensive care unit for less than 24 hours

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
evaluate the success of PRISMIII, PIM2 and PELOD scoring systems in predicting mortality and morbidity	Patients younger than 18 years of age who had undergone congenital heart surgery were evaluated on the first postoperative day in the ICU and parameters were recorded. PRISMIII and PELOD scores were calculated using the most abnormal values in the first 24 hours, and PIM2 score was calculated using the data within the first hour.	3 months
morbidity indicators	Morbidity indicators were determined as the length of ICU stay, total hospital stay, re-intubation, surgical revision, complications and re-admission to the ICU.	3 months
clinical outcomes	Clinical outcomes were determined as 7-day mortality and 30-day mortality.	3 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
to evaluate the relationship of these systems with the STAT(STS-EACTS CHS Mortality Score) category	STAT category was determined according to the surgical procedure.	3 months

Collaborators and Investigators

• Sponsor: Antalya Training and Research Hospital
• Collaborators: Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital; Haydarpasa Numune Training and Research Hospital

Study record dates

Study Major Dates

• Study Start (Actual): February 1, 2019
• Primary Completion (Actual): May 1, 2019
• Study Completion (Actual): May 1, 2019

Study Registration Dates

• First Submitted: April 9, 2021
• First Submitted That Met QC Criteria: April 13, 2021
• First Posted (Actual): April 19, 2021

Study Record Updates

• Last Update Posted (Actual): September 7, 2022
• Last Update Submitted That Met QC Criteria: September 5, 2022
• Last Verified: September 1, 2022

More Information

Terms related to this study

• Keywords: mortality; congenital heart disease; PELOD; STAT; PRISM III; PIM2
• Additional Relevant MeSH Terms: Cardiovascular Diseases; Congenital Abnormalities; Cardiovascular Abnormalities; Heart Diseases; Heart Defects, Congenital
• Other Study ID Numbers: Dr. Siyami Ersek TRH

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No